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Inﬂammatory epilepsyWe report, to our knowledge, the only known pediatric case with encephalopathy and signiﬁcantly elevated
titers of N-type voltage-gated calcium channel antibody (N-type VGCC). The patient, an 8th grader, was pre-
viously healthy and presented with a one-week history of confusion, aphasia, transient fever, headaches, and
dizziness. An underlying autoimmune process was suspected because of inﬂammatory changes in the brain
MRI and multiple focal electrographic seizures captured in the EEG in the absence of CSF pleocytosis. Within
24 h of presentation, the patient was empirically started on immune-modulatory therapy, and a full recovery
was achieved within 3 months of the initial presentation. Immune therapy included high-dose intravenous
(IV) methylprednisolone followed by a 2-week course of dexamethasone and 2 monthly courses of IV immu-
noglobulin (IVIG). He was also treated with anticonvulsants for one month. No tumor has been found to date.
There is a paucity of reports on autoimmune epilepsy or encephalopathy associated with N-type VGCC. Com-
plete resolution of brain lesion, seizure freedom, and full recovery of function following early and aggressive
immunotherapy demonstrate that a high index of suspicion is crucial for early recognition and treatment of
autoimmune encephalitis.
© 2013 The Authors. Published by Elsevier Inc.Open access under CC BY license.1. Introduction
The etiology of encephalitis often remains a mystery. Fortunately,
we are now able to test for an increasing number of antibodies that
offer a deﬁnitive diagnosis for cases that would have been previously
categorized as viral or idiopathic encephalitis [1]. The California
Encephalitis Project found that the frequency of autoimmune enceph-
alitis was greater than any single viral etiology [2]. Anti-N-methyl
D-aspartate receptor (NMDAR) encephalitis was, in fact, the most
frequent cause of immunemediated encephalitis in the pediatric pop-
ulation [2]. Any child who presents with memory deﬁcits, aphasia,CSF, cerebrospinal ﬂuid; EEG,
I, magnetic resonance imaging;
ission computed tomography;
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nc. Open access under CC BY license.seizures, movement disorders, or behavioral changes of a subacute
nature should have autoimmune encephalitis in the differential diag-
nosis. The initial presentation of these patients can vary depending on
the receptor being targeted, but it is crucial to always consider
immune-mediated encephalitis because of the potential for a success-
ful outcome with prompt treatment.
The case we present is of a young man with an elevated titer of
N-type voltage-gated calcium channel antibody and a relatively
acute change in mental status including memory deﬁcits, mood
changes, and transient fever. Our initial instinct was to look for a bac-
terial or viral etiology. When the lumbar puncture was benign, how-
ever, an autoimmune etiology became the leading consideration in
our differential diagnosis. Entities such as fever-induced refractory
epileptic encephalopathy in school-aged children (FIRES) or Rasmus-
sen encephalitis were also considered. Fever-induced refractory epi-
leptic encephalopathy in school-aged children is triggered by fever
and an underlying inﬂammatory response in the suspected culprit
[3]. Although our patient's clinical history was preceded by fever,
his clinical course and prompt positive response to steroids and
IVIG are different from patient with FIRES [3,4] because those patients
present with drug-resistant status epilepticus, CSF pleocytosis, and
perisylvian/mesial temporal lobe abnormalities [4]. Rasmussen en-
cephalitis is a presumed inﬂammatory encephalopathy and a recog-
nized cause of an intractable focal epilepsy or epilepsia partialis
continua (EPC). In most cases, only one hemisphere is involved, and
Table 1
Laboratory data.
Lab test Result
CBC WBC: 5.58 thou/μL; Hgb: 14.5g/dL; Hct: 43%; Plt: 203 thou/μL
CRP, ESR b0.5 mg/dL (0–0.8 mg/dL), 8 mm/h (0–20 mm/h)
Urine drug panel Unremarkable
CSF from lumbar puncture #1 Protein: 28 mg/dL (20–80 mg/dL); glucose: 68 mg/dL (37–65 mg/dL); RBC: b1/mm3 (0–10/mm3);
WBC: 5/mm3 (0–5/mm3), 1% neutrophils (0%), 87% lymphocytes (63–99%)
CSF from lumbar puncture #2 Protein: 32 mg/dL; glucose: 74 mg/dL; RBC: b1/mm3; WBC: 1/mm3, 1% neutrophils, 92% lymphocytes
HSV PCR, meningoencephalitis panel, EBV, HHV-6 Negative
GAD 65 antibody 0.00 nmol/L (b0.02 nmol/L)
Antithyroid antibodies Negative
Paraneoplastic antibody evaluation (serum) Anti-N-type voltage-gated calcium channel antibody = 0.26 nmol/L (≤0.03 nmol/L)
NMDA receptor antibody serum Negative
CBC, complete blood count; WBC, white blood cell; Hgb, hemoglobin; Hct, hematocrit; Plt, platelet; RBC, red blood cell; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate;
CSF, cerebrospinal ﬂuid; HSV, herpes simplex virus; PCR, polymerase chain reaction; EBV, Epstein–Barr virus; HHV, human herpes virus; GAD, glutamate decarboxylase; NMDA,
N-methyl D-aspartic acid.
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youngman's initial MRI scan was reminiscent of this type of unilateral
hemispheric dysfunction, although his lack of EPC or clinically evident
focal seizures or weakness led us away from this diagnosis. The
etiology of Rasmussen encephalitis remains largely unknown, al-
though it is considered a prototype of immune-inﬂammatory epilep-
sy syndrome, and multiple mechanisms have been proposed [2].
Patient's with Rasmussen encephalitis also do not typically respond
readily to immunotherapies, often requiring hemispherectomy to af-
ford seizure freedom [5].
Treatment for encephalitis often needs to be initiated before the
results of conﬁrmatory tests are available. Typically, intravenous im-
munoglobulin and high-dose steroids are used in tandem as initial
therapy. Supportive care and treatment of seizures also play a crucial
role in a favorable outcome. Finding an underlying malignancy in an
adult is more likely than in the pediatric population, but children
should still be screened because a dramatic response can be seen
after tumor removal. There are many types of autoimmune encepha-
litis, and outcomes vary. Our case demonstrates that an autoimmune
etiology must always be considered in patients who present with
acute behavioral change because of the potential for improved out-
come with early administration of immunotherapy [5].
2. Patient presentation
A previously healthy and normally developing 14-year-old boy
presented with one week history of intermittent confusion, memory
deﬁcit, emotional liability, inactivity, and transient fever and
complained of headaches, dizziness, and inability to talk. His brother
had a febrile illness earlier in the week, and the patient experienced
one day of fever, with a maximum temperature of 101.7 °F a day be-
fore the acute change in his mental state. Examination on admission
was remarkable for an ill-appearing, tearful boy with signiﬁcant def-
icits in memory, attention, language, and orientation. He was oriented
to person and place but not time and had difﬁculty naming simple ob-
jects (“bone” instead of “ball”). His digit span was only 2 forward, and
he could not follow the directions for backward digit span.
Head computed tomography (CT) was unremarkable, and a lumbar
puncture (LP) was performed to rule out meningoencephalitis, which
showed only 5 white blood cells (WBCs) with normal glucose and
protein (Table 1). Overnight video electroencephalogram (vEEG)
showed marked left hemisphere dysfunction, a lack of a posterior
dominant rhythm on the left and epileptogenicity with temporal
and occipital maximum. Electroencephalogram captured multiple,
20- to 30-second-long, subtle/stuttering electrographic seizures
emanating from the left hemisphere (Fig. 1). Magnetic resonance
imaging (MRI) revealed cortical thickening involving the left hippo-
campal and parahippocampal gyri and temporal lobes with asso-
ciated abnormal FLAIR signal and restriction. The imaging patternwas most suggestive of an underlying inﬂammatory process such
as encephalitis or prolonged seizure activity (Fig. 2).
2.1. Treatment and hospital course
One gram of intravenous (IV) methylprednisolone (Solumedrol)
was started soon after MRI and EEG and within 24 h of admission. The
patientwas also loadedwith fos-phenytoin and started onmaintenance
fos-phenytoin and topiramate. Intravenous Solumedrol was continued
for a total of 3 days followed by dexamethasone (6 mg TID × 5 days,
6 mg BID × 5 days, 6 mg daily × 5 days, 3 mg daily × 5 days). He con-
tinued to demonstrate waxing and waning mental status after a
high-dose Solumedrol burst. Repeat video-EEG monitoring on day 9
no longer detected seizures but continued to show absence of a posteri-
or dominant rhythm on the left. Single photon emission computed to-
mography scan was performed on day 9 to address continued concern
for ongoing subclinical seizure activity that was not being captured on
EEG. It demonstrated an asymmetric hyperperfusion throughout the
left cerebral hemisphere with posterior predominance, corresponding
to the ﬁndings seen on MRI, which may have reﬂected ongoing seizure
activity (Fig. 3). Repeated doses of lorazepam were given at times of
aphasia, confusion, and sleepiness and produced a transient clinical im-
provement. The patient was, therefore, started on a daily dose of
clobazam. Repeat MRI of the brain (with and without contrast) on day
10 of the hospital stay displayed marked improvement; only subtle T2
hyperintensity, with minimal cortical thickening in the left occipital
and inferior temporal lobes, was noted. The repeat lumbar puncture
on day 10 was again unremarkable (Table 1). The patient was given 2
doses of 1-g/kg intravenous immunoglobulin (IVIG) on days 11 and
12 of hospitalization. On day 18, hewas transferred to inpatient rehabil-
itation with a plan for clobazam monotherapy (10 mg BID).
One month after initial presentation, the paraneoplastic panel
came back positive for N-type calcium channel binding antibody
(0.26 nmol/L [≤0.03 nmol/L]). One additional dose of 1-g/kg IVIG
was given. Testicular ultrasound showed 1-cm hypoechogenicity in
the upper pole of the right testis and bilateral microlithiasis. Repeat
ultrasound and urology follow-up produced no evidence for malig-
nancy. He had completely normal neurological exam at his 3-month
follow-up visit. The most recent MRI of the brain, completed four
months after the initial MRI, demonstrated complete/near-complete
resolution of abnormal T2 hyperintense signal and cortical thicken-
ing. Our patient has been able to go back to school and has not had
any notable residual deﬁcits.
3. Discussion
Early recognition of encephalopathy being related to an underlying
autoimmune mechanism in our patient led to expedited immune-
modulatory therapy and subsequent favorable outcome. Detection of
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Fig. 2. MRI of brain. There is cortical thickening with mildly associated increased T2 signal within the left posterior temporal and mesotemporal lobe with involvement of the
hippocampal and parahippocampal gyri. A. Coronal T2-weighted image; B. axial T2-weighted image.
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response to steroids and IVIG point towards an autoimmunity as the
cause of his symptoms [6]. A case report of two boys with encephalitis
of unknown etiology demonstrated the positive effect of immunother-
apy even in the absence of a known antibody as the cause [7]. Patients
with immune-mediated encephalitis can present with the wide spec-
trum of symptoms including psychosis, catatonia, alterations of be-
havior and memory, seizures, abnormal movements, and autonomic
dysregulation [2]. A high degree of suspicion for an autoimmune etiol-
ogy may, therefore, lead to an early administration of immune-
modulatory therapy and a better outcome [5]. In cases of underlying
malignancy, it is important to also treat and remove the malignant
tumor for successful outcome [5]. As noted in the literature on
anti-NMDAR encephalitis, over 75% of patients have signiﬁcant recov-
ery of neurologic issues when treated early with immunotherapy and
tumor removal whenever applicable [8].
At the time of initial presentation, differential diagnosis included a
parainfectious or infectious etiology in our patient. The two lumbar
punctures, however, were unrevealing (Table 1). Also, we have no rea-
son, at this point, to suspect an underlyingmalignancy. Close follow-up
is necessary as encephalitis often develops prior to the diagnosis of
cancer. The adult guidelines recommend repeating the screening in
3–6 months if primary screening is negative and then every 6 months
for 4 years, except in Lambert–Eaton myasthenia syndrome (LEMS).
For LEMS, follow-up for 2 years is recommended [9].
We are unaware of another case report of a child with encephalitis
secondary to N-type calcium channel receptor antibody. A case report
was found of a 65-year-old woman with small cell lung cancer who
presented with seizure, confusion, dizziness, and lethargy and was sub-
sequently found to have anti-N-type voltage-gated calcium channel titer
elevation (0.42 nmol/L [b0.03 nmol/L]) [10]. N-type voltage-gated calci-
um channel antibody does not have a well-described association with a
speciﬁc paraneoplastic syndrome or underlyingmalignancy [10],where-
as in other antibodies associated with characteristic CNS syndromes, the
presence of various tumors has been found as the underlying source of
the antibody production [6]. N-methyl D-aspartate receptor encephalitis,Fig. 1. Interictal and ictal activities during overnight vEEG monitoring demonstrated marke
A. Intermittent, prominent slowing noted in the left hemisphere maximum in the tempor
occipital region (arrow). Note a lack of posterior dominant rhythm (PDR) on the left a
B. Multiple brief electrographic seizures were captured from the awake and sleep states.
temporal/occipital) seizure origin. Posterior maximum left hemisphere fast activity sp
C. Evolution of rhythmic delta activity spreading throughout the left hemisphere.for example, is often found in association with ovarian teratoma [11].
Lambert–Eastonmyasthenic syndrome (LEMS) and paraneoplastic cere-
bellar degeneration are commonly associatedwith small cell lung cancer
(SCLC) [6,12]. Lambert–Easton myasthenic syndrome is associated with
voltage-gated calcium channels (most of the P/Q typewithN-type found
in about 35%) [12]. The P/Q-type VGCC is also associated with
paraneoplastic cerebellar degeneration. Other synaptic proteins targeted
in limbic encephalitis or autoimmune epilepsies include α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR),
γ-aminobutyric acid (GABA) receptor, voltage-gated potassium channel
complex (VGKC), glutamic acid decarboxylase (GAD) 65, collapsin
response-mediated protein 5 (CRMP5), and ganglionic acetylcholine re-
ceptor [1,12]. Limbic encephalitis is more often a paraneoplastic syn-
drome in adults, while children are far less likely to have an underlying
malignancy [12].
In summary, we present this unique case of a young man with en-
cephalitis and high antibody titers of N-type voltage-gated calcium chan-
nel. Our case underscores the importance of early immune-modulatory
therapy when an underlying autoimmune process is suspected. Patients
presentingwith newonsetmemory deﬁcits, behavioral changes, and sei-
zures of unknown etiology should have autoimmune encephalitis at the
top of their differential diagnosis. Immunotherapy can be started prior to
conﬁrmation, and the timely treatment of these patients can facilitate
improved outcome.Conﬂict of interest
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al and occipital regions. A moderate fast rhythm, 18–20 Hz, was often noted in the left
nd preserved 9-Hz PDR on the right hemisphere.
The seizure onset was subtle and stuttering. Ictal EEG correlate suggests posterior (left
read throughout the left hemisphere and evolved in amplitude and frequency.
Fig. 3. Perfusion SPECT imaging of the brain performed with Tc 99m EDC (Neurolite). 2D grayscale and color maps were produced using iterative reconstruction with and without
attenuation correction. There is asymmetrically increased radiotracer uptake throughout the left cerebral hemisphere in comparison to the right, which is most pronounced in the
left occipital and posterior parietal lobes. These ﬁndings correspond to the areas of signal abnormality and gyral swelling in the left cerebral hemisphere on MRI and suggest that
images were acquired during seizure activity, likely an ictal SPECT.
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